0001225208-14-003602.txt : 20140206
0001225208-14-003602.hdr.sgml : 20140206
20140206203824
ACCESSION NUMBER: 0001225208-14-003602
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140204
FILED AS OF DATE: 20140206
DATE AS OF CHANGE: 20140206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BARD C R INC /NJ/
CENTRAL INDEX KEY: 0000009892
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 221454160
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 730 CENTRAL AVE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
BUSINESS PHONE: 9082778000
MAIL ADDRESS:
STREET 1: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeFord John A
CENTRAL INDEX KEY: 0001403373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06926
FILM NUMBER: 14581610
MAIL ADDRESS:
STREET 1: C R BARD INC
STREET 2: 730 CENTRAL AVENUE
CITY: MURRAY HILL
STATE: NJ
ZIP: 07974
4
1
doc4.xml
X0306
4
2014-02-04
0000009892
BARD C R INC /NJ/
BCR
0001403373
DeFord John A
C/O C. R. BARD, INC.
730 CENTRAL AVENUE
MURRAY HILL
NJ
07974
1
Sr. VP Sci Tech and Clin Afrs
Common Stock
2014-02-04
4
M
0
11252.0000
84.5750
A
44795.2361
D
Common Stock
2014-02-04
4
M
0
10364.0000
86.1450
A
55159.2361
D
Common Stock
2014-02-04
4
S
0
538.0000
128.0276
D
54621.2361
D
Common Stock
2014-02-04
4
S
0
21078.0000
127.5091
D
33543.2361
D
Common Stock
14.4390
I
401(k) Plan
Option (Right to Buy)
86.1450
2014-02-04
4
M
0
10364.0000
0.0000
D
2020-12-08
Common Stock
10364.0000
0.0000
D
Option (Right to Buy)
84.5750
2014-02-04
4
M
0
11252.0000
0.0000
D
2021-12-14
Common Stock
11252.0000
11253.0000
D
Represents the weighted average sales price for price increments ranging from $128 to $128.06. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $127 to $127.98. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 1.781 shares acquired under the Company's 401(k) Plan from December 10, 2013 to February 3, 2014.
Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Options fully vested in accordance with schedule upon achievement of certain performance criteria.
Options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this original grant, 11,252 options are fully vested and the remaining 11,253 options will vest in two equal annual installments on 12/14/2014 and 12/14/2015.
Myra McGinley, Attorney-in-Fact
2014-02-06